Results     18-May-23
Announcements
Zydus Lifesciences consolidated net profit declines 25.36% in the March 2023 quarter
Sales rise 29.68% to Rs 4852.50 crore
Net profit of Zydus Lifesciences declined 25.36% to Rs 296.60 crore in the quarter ended March 2023 as against Rs 397.40 crore during the previous quarter ended March 2022. Sales rose 29.68% to Rs 4852.50 crore in the quarter ended March 2023 as against Rs 3741.80 crore during the previous quarter ended March 2022.

For the full year,net profit declined 56.31% to Rs 1960.30 crore in the year ended March 2023 as against Rs 4487.30 crore during the previous year ended March 2022. Sales rose 13.83% to Rs 16877.80 crore in the year ended March 2023 as against Rs 14827.60 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales4852.503741.80 30 16877.8014827.60 14
OPM %25.8819.18 -22.8722.53 -
PBDT1265.70758.30 67 3916.603438.40 14
PBT1087.10572.90 90 3193.902725.40 17
NP296.60397.40 -25 1960.304487.30 -56

Previous News
  Zydus Lifesciences declare Quarterly Result
 ( Corporate News - 09-May-24   13:52 )
  Zydus' transdermal patch manufacturing facility completes USFDA inspection
 ( Corporate News - 01-Oct-24   12:26 )
  Zydus enters into non-exclusive patent licensing agreement with Takeda
 ( Corporate News - 17-Jul-24   15:41 )
  Zydus Lifesciences Ltd drops for fifth straight session
 ( Hot Pursuit - 19-Sep-24   13:35 )
  Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
 ( Corporate News - 14-Jun-24   13:42 )
  Zydus Lifesciences Ltd spurts 2.36%, rises for third straight session
 ( Hot Pursuit - 17-May-24   13:05 )
  Sentynl, a Zydus company, acquires Zokinvy® (Lonafarnib)
 ( Corporate News - 04-May-24   10:42 )
  Zydus Lifesciences Ltd spurts 7.01%, up for third straight session
 ( Hot Pursuit - 12-Feb-24   13:05 )
  Zydus Life’s Ahmedabad facility gets EIR from USFDA
 ( Hot Pursuit - 01-Oct-24   12:13 )
  Zydus Life gains after receiving USFDA nod for Chlorpromazine Hydrochloride Injection
 ( Hot Pursuit - 14-Mar-24   13:05 )
  Zydus receives USFDA final approval for Chlorpromazine Hydrochloride Injection
 ( Corporate News - 14-Mar-24   12:24 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top